BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22658441)

  • 1. A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.
    Moran MS; Ma S; Jagsi R; Yang TJ; Higgins SA; Weidhaas JB; Wilson LD; Lloyd S; Peschel R; Gaudreau B; Rockwell S
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):40-6. PubMed ID: 22658441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
    Wyatt G; Sikorskii A; Wills CE; Su H
    Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death.
    Rakovitch E; Pignol JP; Chartier C; Ezer M; Verma S; Dranitsaris G; Clemons M
    Breast Cancer Res Treat; 2005 Mar; 90(2):139-48. PubMed ID: 15803360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Pedersen CG; Christensen S; Jensen AB; Zachariae R
    Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study.
    Helyer LK; Chin S; Chui BK; Fitzgerald B; Verma S; Rakovitch E; Dranitsaris G; Clemons M
    BMC Cancer; 2006 Feb; 6():39. PubMed ID: 16504038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
    Swarup AB; Barrett W; Jazieh AR
    Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring frontiers: use of complementary and alternative medicine among patients with early-stage breast cancer.
    Saghatchian M; Bihan C; Chenailler C; Mazouni C; Dauchy S; Delaloge S
    Breast; 2014 Jun; 23(3):279-85. PubMed ID: 24529905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
    Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
    Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.
    Ashikaga T; Bosompra K; O'Brien P; Nelson L
    Support Care Cancer; 2002 Oct; 10(7):542-8. PubMed ID: 12324809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a mixed methods research design to investigate complementary alternative medicine (CAM) use among women with breast cancer in Ireland.
    Fox P; Butler M; Coughlan B; Murray M; Boland N; Hanan T; Murphy H; Forrester P; O' Brien M; O' Sullivan N
    Eur J Oncol Nurs; 2013 Aug; 17(4):490-7. PubMed ID: 23182602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported use of complementary and alternative medicine in patients with previous acute coronary syndrome.
    Decker C; Huddleston J; Kosiborod M; Buchanan DM; Stoner C; Jones A; Banerjee S; Spertus JA
    Am J Cardiol; 2007 Apr; 99(7):930-3. PubMed ID: 17398186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of complementary/alternative services by women with breast cancer.
    Gray RE; Fitch M; Goel V; Franssen E; Labrecque M
    J Health Soc Policy; 2003; 16(4):75-84. PubMed ID: 12943333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study.
    Saxe GA; Madlensky L; Kealey S; Wu DP; Freeman KL; Pierce JP
    Integr Cancer Ther; 2008 Sep; 7(3):122-9. PubMed ID: 18956493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer.
    Owens B
    Oncol Nurs Forum; 2007 Jul; 34(4):E42-50. PubMed ID: 17723972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary medicine use among women enrolled in a genetic testing program.
    DiGianni LM; Kim HT; Emmons K; Gelman R; Kalkbrenner KJ; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):321-6. PubMed ID: 12692106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.